| Thomas Baldwin, MD | |
|
20805 W 151st St, Building 2 Suite 400, Olathe, KS 66061-7249 | |
| (913) 780-4900 | |
| (913) 780-0949 |
| Full Name | Thomas Baldwin |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 41 Years |
| Location | 20805 W 151st St, Olathe, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104872746 | NPI | - | NPPES |
| 100115030B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0420535 (Kansas) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 0420535 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overland Park Reg Med Ctr | Overland park, KS | Hospital |
| Menorah Medical Center | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Heart And Vascular Specialists Llc | 7618122417 | 81 |
| Midwest Heart And Vascular Specialists Llc | 7618122417 | 81 |
News Archive
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
High-density lipoprotein, known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".
State officials are creating two task forces to gather input on a consulting firm's report on the future of Georgia's Medicaid and PeachCare programs. One task force will involve medical provider groups, including representatives of hospital and physician organizations. The second grouping will review the Navigant report's recommendation to revamp services for the "aged, blind and disabled" populations.
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
The Global Alliance for TB Drug Development and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis, including drug resistant strains of the disease.
› Verified 9 days ago
| Entity Name | Olathe Health Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784639 PECOS PAC ID: 7618881905 Enrollment ID: O20031119000719 |
News Archive
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
High-density lipoprotein, known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".
State officials are creating two task forces to gather input on a consulting firm's report on the future of Georgia's Medicaid and PeachCare programs. One task force will involve medical provider groups, including representatives of hospital and physician organizations. The second grouping will review the Navigant report's recommendation to revamp services for the "aged, blind and disabled" populations.
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
The Global Alliance for TB Drug Development and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis, including drug resistant strains of the disease.
› Verified 9 days ago
| Entity Name | Midwest Heart & Vascular Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760736615 PECOS PAC ID: 7618122417 Enrollment ID: O20130307000263 |
News Archive
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
High-density lipoprotein, known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".
State officials are creating two task forces to gather input on a consulting firm's report on the future of Georgia's Medicaid and PeachCare programs. One task force will involve medical provider groups, including representatives of hospital and physician organizations. The second grouping will review the Navigant report's recommendation to revamp services for the "aged, blind and disabled" populations.
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
The Global Alliance for TB Drug Development and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis, including drug resistant strains of the disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Baldwin, MD 12200 W 106th St Ste 320, Overland Park, KS 66215-2305 Ph: (913) 894-9015 | Thomas Baldwin, MD 20805 W 151st St, Building 2 Suite 400, Olathe, KS 66061-7249 Ph: (913) 780-4900 |
News Archive
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
High-density lipoprotein, known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".
State officials are creating two task forces to gather input on a consulting firm's report on the future of Georgia's Medicaid and PeachCare programs. One task force will involve medical provider groups, including representatives of hospital and physician organizations. The second grouping will review the Navigant report's recommendation to revamp services for the "aged, blind and disabled" populations.
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
The Global Alliance for TB Drug Development and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis, including drug resistant strains of the disease.
› Verified 9 days ago
Anjalee Goel Carlson, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2090 W Dartmouth St, Olathe, KS 66061 Phone: 913-356-8300 Fax: 913-356-8711 | |
Dr. Larry R Corum, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 208, Olathe, KS 66061 Phone: 913-780-4000 Fax: 913-780-4038 | |
Dr. Everett Middleton Murphy Iii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 20375 W 151st St, Suite 451, Olathe, KS 66061 Phone: 913-829-0446 Fax: 913-829-7829 | |
Dominique M Crain, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, 451, Olathe, KS 66061 Phone: 913-829-0446 | |
Michael O'bryan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13875 W 115th Ter, Olathe, KS 66062 Phone: 913-323-7107 | |
Dr. Jamil Abuzetun, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20805 W 151st St # 400, Olathe, KS 66061 Phone: 913-780-4900 Fax: 913-780-0949 |